Comparative activity of ceftobiprole against Gram-positive and Gram-negative isolates from Europe and the Middle East: the CLASS study

Gian María Rossolini(University of Siena), Antonio Goglio, Robert K. Flamm(JMI Laboratories), Matthew Dryden(Royal Hampshire County Hospital), F. Giacomo, Marianne Abele‐Horn(Quotient Clinical (United Kingdom)), P. Lannote, H. Malamou‐Lada, Julie Cremniter, Roman S. Kozlov(Smolensk State Medical University), F. Ghaly, E. Lee(Janssen (Belgium)), T. Fosse, AS Moses, Tzvetan Velinov, Giovanni Gesu, Helena Žemličková, Vincent Jarlier(Sorbonne Université), E. Jacobs(Janssen (Switzerland)), Hélène Marchandin(Centre National de la Recherche Scientifique), W. Pfister, Sabine Schubert(Biology of Infection), Reinier Mutters, O. Paniara, N Vakalis, J. Papaparaskevas(Johnson & Johnson (Germany)), Encho Savov(Military Medical Academy), Harald Seifert(German Center for Infection Research), Colin R. MacKenzie(Düsseldorf University Hospital), Pierre-Yves Donnio, Alvaro Quintana(Johnson & Johnson (United States)), Ian Morrissey, J.M. Läuffer(Janssen (Switzerland)), Laurie Gutmann(University of Iowa Hospitals and Clinics), G. Rahav, Jacques Tankovic(Sorbonne Université), Pierangelo Clerici(Creative Research Enterprises (United States)), Claude–James Soussy, Jean‐Louis Fauchere(Centre Hospitalier Universitaire de Poitiers), C. Schoerner(Johnson & Johnson (Germany)), Sören Gatermann(Ruhr University Bochum), Manfred Fille, U. Mai, F.-J. Schmitz, E.G. Smyth(Quotient Clinical (United Kingdom)), Max Maurin(Centre National de la Recherche Scientifique), Dimitra Petropoulou(General Hospital of Nikea), José L. Pons(Northwestern University)
Journal of Antimicrobial Chemotherapy
November 3, 2010
Cited by 27


Related Papers